cgs 10746b has been researched along with dextroamphetamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boja, JW; Schechter, MD | 1 |
1 other study(ies) available for cgs 10746b and dextroamphetamine
| Article | Year |
|---|---|
CGS 10746B is able to attenuate the effects of amphetamine: further evidence for dopaminergic mediation.
Topics: Alkaloids; Animals; Antipsychotic Agents; Apomorphine; Cocaine; Conditioning, Operant; Dextroamphetamine; Discrimination, Psychological; Dopamine; Dose-Response Relationship, Drug; Male; Rats; Thiazepines | 1988 |